1-5 of 5
Kerry S. Campbell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The FcγRIIIA (CD16) L48-H/R polymorphism enhances NK cell-mediated antibody-dependent cellular cytotoxicity by promoting serial killing

Nicholas A. Maskalenko, Sam Zahroun, Oxana Tsygankova, Nadia Anikeeva, Yuri Sykulev, Kerry S. Campbell
Journal: Cancer Immunology Research
Cancer Immunol Res (2024)
https://doi.org/10.1158/2326-6066.CIR-24-0384
Published: 12 December 2024
View article titled, The FcγRIIIA (CD16) L48-H/R polymorphism enhances NK cell-mediated antibody-dependent cellular cytotoxicity by promoting serial killing
Open the PDF for The FcγRIIIA (CD16) L48-H/R polymorphism enhances NK cell-mediated antibody-dependent cellular cytotoxicity by promoting serial killing in another window
Includes: Multimedia, Supplementary data
Journal Articles

Mystery Checkpoint Revealed: KIR3DL3 Finally Found a Ligand in HHLA2

Kerry S. Campbell
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (2): 128.
https://doi.org/10.1158/2326-6066.CIR-20-0996
Published: 03 February 2021
View article titled, Mystery Checkpoint Revealed: KIR3DL3 Finally Found a Ligand in HHLA2
Open the PDF for Mystery Checkpoint Revealed: KIR3DL3 Finally Found a Ligand in HHLA2 in another window
Journal Articles

Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma

Tatiana Pazina, Ashley M. James, Kimberly B. Colby, Yibin Yang, Andrew Gale, Amy Jhatakia, Alper Y. Kearney, Robert F. Graziano, Natalie A. Bezman, Michael D. Robbins, Adam D. Cohen, Kerry S. Campbell
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (10): 1633–1646.
https://doi.org/10.1158/2326-6066.CIR-18-0579
Published: 01 October 2019
View article titled, Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma
Open the PDF for Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA

Kiran Kundu, Susmita Ghosh, Rhitajit Sarkar, Avishay Edri, Michael Brusilovsky, Orly Gershoni-Yahalom, Rami Yossef, Avishai Shemesh, Jean-Charles Soria, Vladimir Lazar, Ben-Zion Joshua, Kerry S. Campbell, Moshe Elkabets, Angel Porgador
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (7): 1120–1134.
https://doi.org/10.1158/2326-6066.CIR-19-0023
Published: 01 July 2019
View article titled, Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA
Open the PDF for Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA in another window
Includes: Supplementary data
Journal Articles

PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection

Alexander W. MacFarlane, IV, Mowafaq Jillab, Elizabeth R. Plimack, Gary R. Hudes, Robert G. Uzzo, Samuel Litwin, Essel Dulaimi, Tahseen Al-Saleem, Kerry S. Campbell
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (4): 320–331.
https://doi.org/10.1158/2326-6066.CIR-13-0133
Published: 03 April 2014
View article titled, PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
Open the PDF for PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection in another window
Includes: Supplementary data